{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:55Z","timestamp":1793356855192,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101308","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:36:16Z","timestamp":1790955376000},"page":"101308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancing brachytherapy: The GEC-ESTRO strategic vision"],"prefix":"10.1016","volume":"62","author":[{"given":"Frank-Andr\u00e9","family":"Siebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kirisits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Niehoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Slocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratislav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Sturdza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101308_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110283","article-title":"European Society of Radiotherapy and Oncology (ESTRO) strategy 2024-2026: growth and diversification in a rapidly changing world","volume":"196","author":"Kirby","year":"2024","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101308_bb0010","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.canrad.2022.04.002","article-title":"The inverse square law: a basic principle in brachytherapy","volume":"26","author":"Marci\u00e9","year":"2022","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.ctro.2026.101308_bb0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101308_bb0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicentre cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101308_bb0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2023.11.007","article-title":"Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study","volume":"119","author":"Han","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl. 1","key":"10.1016\/j.ctro.2026.101308_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the prostate Cancer results study group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ctro.2026.101308_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109632","article-title":"Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients","volume":"183","author":"Miszczyk","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0040","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Prostate Cancer (v2.2025)","author":"National Comprehensive Cancer Network","year":"2025"},{"issue":"10015","key":"10.1016\/j.ctro.2026.101308_bb0045","first-page":"387","volume":"16","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101308_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110979","article-title":"Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review","volume":"209","author":"Hannoun-Levi","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0055","first-page":"17","article-title":"From applicator-based (Paris system) implantations to rhinoseptoplasty: the concept of anatomic implantation for interventional radiotherapy in squamous cell carcinoma of the nasal vestibule. Short term results in a monoinstitutional series","volume":"8","author":"Tropiano","year":"2024","journal-title":"Mini-invasive Surg"},{"key":"10.1016\/j.ctro.2026.101308_bb0060","first-page":"386","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ctro.2026.101308_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(98)00420-9","article-title":"Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants","volume":"43","author":"Kini","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101308_bb0070","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1118\/1.4747264","article-title":"Report of the task group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation","volume":"39","author":"Beaulieu","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2026.101308_bb0075","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1002\/mp.16571","article-title":"AAPM WGDCAB report 372: a joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy","volume":"50","author":"Beaulieu","year":"2023","journal-title":"Med Phys"},{"issue":"10","key":"10.1016\/j.ctro.2026.101308_bb0080","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk factors for local failure following Chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical Cancer: results from the EMBRACE-I study","volume":"41","author":"Schmid","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101308_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with Radiochemotherapy in locally advanced cervical Cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109748","article-title":"EviGUIDE \u2013 a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer","volume":"186","author":"Ecker","year":"2023","journal-title":"Radiother Oncol"},{"issue":"52","key":"10.1016\/j.ctro.2026.101308_bb0095","first-page":"100924","article-title":"Brachytherapy: perspectives for combined treatments with immunotherapy","volume":"19","author":"Serre","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0100","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(24)02231-1","article-title":"Pembrolizumab for locally advanced cervical cancer","volume":"404","author":"Schmid","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101308_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2021.07.004","article-title":"PSA: Declining utilization of prostate brachytherapy","volume":"21","author":"Andring","year":"2022","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.ctro.2026.101308_bb0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.brachy.2017.03.010","article-title":"The declining utilization of brachytherapy for the treatment of prostate cancer: can magnetic resonance imaging reverse the trend?","volume":"16","author":"Mahmood","year":"2017","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.ctro.2026.101308_bb0115","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl","volume":"11","author":"P\u00f6tter","year":"2018","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101308_bb0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.brachy.2023.12.001","article-title":"Brachytherapy for rectal and anal cancer: where are we and current perspectives?","volume":"23","author":"Stewart","year":"2024","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ctro.2026.101308_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14639\/0392-100X-N2786","article-title":"Management of nasal vestibule carcinomas: recommendations by the oncological Committee of the Italian Society of otorhinolaryngology - head and neck surgery","volume":"44","author":"Bussu","year":"2024","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"10.1016\/j.ctro.2026.101308_bb0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s13187-017-1169-8","article-title":"A review of shared decision-making and patient decision aids in radiation oncology","volume":"32","author":"Woodhouse","year":"2017","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.ctro.2026.101308_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13014-024-02415-8","article-title":"Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov","volume":"19","author":"Chen","year":"2024","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101308_bb0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00066-022-01912-7","article-title":"First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy","volume":"198","author":"Karius","year":"2022","journal-title":"Strahlenther Onkol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101308_bb0145","doi-asserted-by":"crossref","DOI":"10.1118\/1.4810943","article-title":"In vivo dosimetry in brachytherapy","volume":"40","author":"Tanderup","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2026.101308_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110659","article-title":"Randomized trials: when scientific rigor meets field reality","volume":"203","author":"Hannoun-Levi","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2022.10.030","article-title":"Brachytherapy training survey among radiation oncology residents in Europe","volume":"177","author":"Sturdza","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13859","article-title":"AAPM BTSC report 377: physicist brachytherapy training in 2021-a survey of therapeutic medical physics residency program directors","volume":"24","author":"Aima","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ctro.2026.101308_bb0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.brachy.2025.05.006","article-title":"Joint ABS\/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physicians","volume":"24","author":"Keyes","year":"2025","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101308_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semradonc.2019.09.001","article-title":"Brachytherapy future directions","volume":"30","author":"Cunha","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101308_bb0175","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/imj.14448","article-title":"Evolving role of Instagram in #medicine","volume":"49","author":"Wong","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.ctro.2026.101308_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2012.03.010","article-title":"ESTRO 2012 strategy meeting: vision for radiation oncology","volume":"103","author":"Valentini","year":"2012","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:07:59Z","timestamp":1793354879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082600203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":36,"alternative-id":["S240563082600203X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101308","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing brachytherapy: The GEC-ESTRO strategic vision","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101308"}}